| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $1.48B | +17.0% |
| Cost of Revenue | $379.9M | +15.1% |
| Gross Profit | $1.10B | +17.7% |
| R&D Expense | $365.8M | +7.0% |
| SG&A Expense | $175.2M | +9.1% |
| Operating Income | -$54.9M | +57.7% |
| Interest Expense | $25.3M | -3.2% |
| Pre-tax Income | -$31.6M | +74.3% |
| Income Tax | $76.5M |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $727.5M | +34.6% |
| Short-term Investments | $669.7M | +23.1% |
| Accounts Receivable | $375.6M | +16.3% |
| Current Assets | $1.93B | +26.1% |
| Total Assets | $2.59B | +15.6% |
| Current Liabilities | $1.01B | +15.7% |
| Long-term Debt | $569.7M | +0.2% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $266.2M | +78.9% |
| Capital Expenditures | $4.3M | +25.9% |
| Investing Cash Flow | -$118.7M | +58.8% |
| Financing Cash Flow | $40.9M | +2.2% |
| Free Cash Flow | $261.8M | +80.2% |
| +141.5% |
| Net Income | -$108.1M | -275.2% |
| EPS (Basic) | -$1.04 | -267.7% |
| EPS (Diluted) | -$1.04 | -276.3% |
| Total Liabilities |
| $1.67B |
| +10.7% |
| Stockholders' Equity | $927.2M | +25.6% |